CN104288412B - 一种治疗代谢综合征的中药组合物 - Google Patents
一种治疗代谢综合征的中药组合物 Download PDFInfo
- Publication number
- CN104288412B CN104288412B CN201410620763.6A CN201410620763A CN104288412B CN 104288412 B CN104288412 B CN 104288412B CN 201410620763 A CN201410620763 A CN 201410620763A CN 104288412 B CN104288412 B CN 104288412B
- Authority
- CN
- China
- Prior art keywords
- parts
- metabolic syndrome
- chinese medicine
- treatment
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 52
- 239000000203 mixture Substances 0.000 title claims abstract description 41
- 208000001145 Metabolic Syndrome Diseases 0.000 title claims abstract description 35
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 title claims abstract description 35
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 34
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 34
- 238000011282 treatment Methods 0.000 claims abstract description 29
- 244000080767 Areca catechu Species 0.000 claims abstract description 17
- 235000006226 Areca catechu Nutrition 0.000 claims abstract description 17
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 17
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 17
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 17
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 17
- 244000197580 Poria cocos Species 0.000 claims abstract description 17
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 17
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 16
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 16
- 239000000843 powder Substances 0.000 claims abstract description 16
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 15
- 240000001341 Reynoutria japonica Species 0.000 claims abstract description 15
- 235000018167 Reynoutria japonica Nutrition 0.000 claims abstract description 15
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract description 14
- 239000000463 material Substances 0.000 claims abstract description 13
- 230000000694 effects Effects 0.000 abstract description 26
- 210000004369 blood Anatomy 0.000 abstract description 24
- 239000008280 blood Substances 0.000 abstract description 24
- 210000004185 liver Anatomy 0.000 abstract description 15
- 210000000952 spleen Anatomy 0.000 abstract description 15
- 210000003734 kidney Anatomy 0.000 abstract description 14
- 206010022489 Insulin Resistance Diseases 0.000 abstract description 12
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract description 12
- 150000002632 lipids Chemical class 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 208000004880 Polyuria Diseases 0.000 abstract description 8
- 230000035619 diuresis Effects 0.000 abstract description 8
- 210000002784 stomach Anatomy 0.000 abstract description 8
- 230000003213 activating effect Effects 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 5
- 238000000034 method Methods 0.000 abstract description 5
- 238000010792 warming Methods 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 10
- 241000700159 Rattus Species 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- XUKUURHRXDUEBC-KAYWLYCHSA-N Atorvastatin Chemical group C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 description 6
- XUKUURHRXDUEBC-UHFFFAOYSA-N Atorvastatin Natural products C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CCC(O)CC(O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-UHFFFAOYSA-N 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 229960005370 atorvastatin Drugs 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 108010023302 HDL Cholesterol Proteins 0.000 description 5
- 102000004877 Insulin Human genes 0.000 description 5
- 108090001061 Insulin Proteins 0.000 description 5
- 230000002218 hypoglycaemic effect Effects 0.000 description 5
- 229940125396 insulin Drugs 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000004611 Abdominal Obesity Diseases 0.000 description 3
- 206010065941 Central obesity Diseases 0.000 description 3
- 208000032928 Dyslipidaemia Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000001603 reducing effect Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000012109 statistical procedure Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 208000017170 Lipid metabolism disease Diseases 0.000 description 2
- 244000292697 Polygonum aviculare Species 0.000 description 2
- 235000006386 Polygonum aviculare Nutrition 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 241001065361 Gynostemma Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 102100023915 Insulin Human genes 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 229940127003 anti-diabetic drug Drugs 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000005976 liver dysfunction Effects 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000015263 low fat diet Nutrition 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000001991 pathophysiological effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229960004586 rosiglitazone Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Abstract
Description
组别 | INS(mU/L) | HONA-IR |
正常组 | 0.671±0.142* | 1.75±0.351** |
模型组 | 0.915±0.237 | 2.57±0.472 |
二甲双胍组 | 0.662±0.174 * | 1.96±0.287* |
阿托伐他汀组 | 0.827±0.218 | 2.28±0.423 |
TCM-H | 0.618±0.153 ** △ | 1.77±0.355 ** △ |
TCM-M | 0.657±0.129 *△ | 1.83±0.416*△ |
TCM-L | 0.683±0.148 *△ | 1.86±0.332 * △ |
组别 | 例数(人) | 显效(人) | 有效(人) | 无效(人) | 总有效率(%) |
治疗组 | 43 | 25 | 15 | 3 | 93.02 |
对照组 | 41 | 20 | 14 | 7 | 82.93 |
项目 | 治疗组治疗前 | 治疗组治疗后 | 对照组治疗前 | 对照组治疗后 |
FBG(mmol/L) | 6.18±1.02 | 5.89±1.43 | 6.2±1.37 | 5.31±1.28* |
FINS(mIU/L) | 10.17±2.18 | 8.42±1.67* | 10.21±2.51 | 8.32±2.04* |
HOMA-IR | 2.79±0.56 | 2.12±0.37* | 2.77±0.45 | 2.01±0.69* |
WC(cm) | 93.1±22.34 | 86.4±19.52* | 92.5±26.14 | 90.2±21.58 |
TC(mmol/L) | 5.46±1.05 | 4.86±0.64* | 5.39±1.27 | 5.17±1.51 |
TG(mmol/L) | 2.89±0.86 | 1.92±0.58**△ | 2.83±0.79 | 2.49±0.77 |
HDL-C(mmol/L) | 0.86±0.22 | 1.27±0.36* | 0.89±0.39 | 1.14±0.42* |
LDL-C(mmol/L) | 3.46±1.12 | 2.89±0.97*△ | 3.45±0.81 | 3.28±1.24 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410620763.6A CN104288412B (zh) | 2014-11-07 | 2014-11-07 | 一种治疗代谢综合征的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410620763.6A CN104288412B (zh) | 2014-11-07 | 2014-11-07 | 一种治疗代谢综合征的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104288412A CN104288412A (zh) | 2015-01-21 |
CN104288412B true CN104288412B (zh) | 2018-04-20 |
Family
ID=52308523
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410620763.6A Expired - Fee Related CN104288412B (zh) | 2014-11-07 | 2014-11-07 | 一种治疗代谢综合征的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104288412B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105311225A (zh) * | 2015-11-20 | 2016-02-10 | 宋苏萍 | 一种儿童非感染性咳嗽治疗用雾化液 |
CN105311224A (zh) * | 2015-11-20 | 2016-02-10 | 宋苏萍 | 一种儿童用雾化吸入药物制备方法 |
CN105920514A (zh) * | 2016-04-27 | 2016-09-07 | 青岛友诚高新技术有限公司 | 治疗代谢综合征的中药组合物 |
CN105749179A (zh) * | 2016-04-28 | 2016-07-13 | 于华 | 治疗代谢综合征的中药组合物 |
CN111513155B (zh) * | 2020-05-21 | 2022-11-08 | 云南中医药大学 | 一种防治脂代谢异常的组合物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101467577A (zh) * | 2007-12-27 | 2009-07-01 | 天津天阜康生物技术发展有限公司 | 一种降脂茶及其制备方法 |
CN101243882B (zh) * | 2008-03-27 | 2011-05-04 | 北京惠中铭捷生物科技有限公司 | 具有降血脂功能的保健食品及其制备方法 |
CN102188560A (zh) * | 2010-03-08 | 2011-09-21 | 张锡林 | 中药治疗高血脂 |
-
2014
- 2014-11-07 CN CN201410620763.6A patent/CN104288412B/zh not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101467577A (zh) * | 2007-12-27 | 2009-07-01 | 天津天阜康生物技术发展有限公司 | 一种降脂茶及其制备方法 |
CN101243882B (zh) * | 2008-03-27 | 2011-05-04 | 北京惠中铭捷生物科技有限公司 | 具有降血脂功能的保健食品及其制备方法 |
CN102188560A (zh) * | 2010-03-08 | 2011-09-21 | 张锡林 | 中药治疗高血脂 |
Non-Patent Citations (1)
Title |
---|
归芍药散治疗血脂异常痰瘀互结证的临床观察;宋晓宇等;《河北中医药学报》;20090331;第24卷(第1期);第12-14页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104288412A (zh) | 2015-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102058767B (zh) | 治疗老年慢性支气管炎的中药及该中药丸剂的制备方法 | |
CN104288412B (zh) | 一种治疗代谢综合征的中药组合物 | |
CN108524776B (zh) | 一种治疗气阴两虚型糖尿病的药物及其制备方法 | |
CN101711848B (zh) | 一种辅助治疗肿瘤的中药组合物 | |
CN103301356B (zh) | 一种慢性肾衰竭用灌肠液制备方法 | |
CN103520655A (zh) | 一种治疗寻常型银屑病的中药组合物及其制备方法 | |
CN1679892A (zh) | 治疗癌症的口服液及其生产方法 | |
CN104001045A (zh) | 一种用于治疗犬肺炎的药物及其制备方法 | |
CN104815243A (zh) | 一种萎缩性阴道炎外洗液制备方法 | |
CN105687788A (zh) | 一种软化血管的药物组合物及其应用 | |
CN106075020A (zh) | 一种具有治疗糖尿病功效的灵芝复方颗粒剂 | |
CN102274396B (zh) | 治疗糖尿病肾病的中药及其制备方法 | |
CN104857210A (zh) | 一种治疗脂肪肝的中药组合制剂及其制备方法 | |
CN114748603A (zh) | 一种防治新冠病毒肺炎变异或复阳的药食同源组合物和应用 | |
CN103341095B (zh) | 一种慢性肾衰竭用灌肠液 | |
CN105168946A (zh) | 一种治疗糖尿病的中药组合物及其用途 | |
CN114712466B (zh) | 一种具有减肥养颜功效的药物及其制备方法 | |
CN104758733A (zh) | 一种治疗老年性阴道炎的外洗剂 | |
CN107913389A (zh) | 一种治疗甲状腺肿大的中药组合物及其制备方法 | |
CN105709176A (zh) | 一种治疗心血瘀阻型心悸的中药组合物及其制备方法 | |
CN106728828A (zh) | 一种治疗冠心病的中药制剂及其制备工艺 | |
CN106139116A (zh) | 一种可防治肥胖ⅱ型糖尿病合并血脂异常的中药组合物 | |
CN106727926B (zh) | 抗肝纤维化及治疗肝硬化的药物及制备方法 | |
CN104826068A (zh) | 一种祛风除湿的药物及其制备方法 | |
CN115317580A (zh) | 一种清除幽门螺杆菌的中药制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 450008 Jinshui Road, Zhengzhou, Henan, No. 1 Applicant after: Henan University of traditional Chinese Medicine Address before: 450008 Jinshui Road, Zhengzhou, Henan, No. 1 Applicant before: Henan University of Traditional Chinese Medicine |
|
CB02 | Change of applicant information | ||
CB03 | Change of inventor or designer information |
Inventor after: Cheng Kai Inventor after: Li Shasha Inventor after: Xie Yadan Inventor after: Li Zhiheng Inventor after: Chen Tuanying Inventor after: Li Zhenzhen Inventor after: Xu Qianlei Inventor after: Zhang Yan Inventor after: Li Xiaobing Inventor after: Zhao Xin Inventor after: Chang Zhenghui Inventor after: Zhang Bo Inventor before: Cheng Kai Inventor before: Li Zhiheng Inventor before: Chen Tuanying Inventor before: Li Xiaobing Inventor before: Wang Jihui Inventor before: Huo Lei Inventor before: Chang Zhenghui Inventor before: Zhang Bo Inventor before: Li Shasha Inventor before: Xie Yadan |
|
CB03 | Change of inventor or designer information | ||
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 450018 Jinshui East Road, Zheng Dong new area, Zhengzhou, Henan Province, No. 156 Patentee after: Henan University of traditional Chinese Medicine Address before: 450008 Jinshui Road, Zhengzhou, Henan, No. 1 Patentee before: Henan University of traditional Chinese Medicine |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180420 Termination date: 20181107 |
|
CF01 | Termination of patent right due to non-payment of annual fee |